These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. Jafri H; Ahmad I J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964 [TBL] [Abstract][Full Text] [Related]
8. Chemical composition and antifungal activity of Satureja hortensis L. essentiall oil against planktonic and biofilm growth of Candida albicans isolates from buccal lesions of HIV(+) individuals. Sharifzadeh A; Khosravi AR; Ahmadian S Microb Pathog; 2016 Jul; 96():1-9. PubMed ID: 27126187 [TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS profiling and analysis of Bacillus licheniformis extracellular proteins for antifungal potential against Candida albicans. Prusty JS; Kumar A J Proteomics; 2024 Jul; 303():105228. PubMed ID: 38878881 [TBL] [Abstract][Full Text] [Related]
10. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Braga PC; Culici M; Alfieri M; Dal Sasso M Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858 [TBL] [Abstract][Full Text] [Related]
11. A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro. Nieminen MT; Novak-Frazer L; Rautemaa V; Rajendran R; Sorsa T; Ramage G; Bowyer P; Rautemaa R PLoS One; 2014; 9(5):e97864. PubMed ID: 24867320 [TBL] [Abstract][Full Text] [Related]
12. Relative Abundances of Candida albicans and Candida glabrata in Olson ML; Jayaraman A; Kao KC Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422 [No Abstract] [Full Text] [Related]
13. Autophagy regulation of Liu S; Jiang L; Miao H; Lv Y; Zhang Q; Ma M; Duan W; Huang Y; Wei X Biofouling; 2022 Oct; 38(9):926-939. PubMed ID: 36476055 [TBL] [Abstract][Full Text] [Related]
14. Carnosol inhibits the growth and biofilm of Candida albicans. Yang L; Sui Y; Zhong L; Ma T; Ma Z; Liu X J Mycol Med; 2022 May; 32(2):101234. PubMed ID: 34929524 [TBL] [Abstract][Full Text] [Related]
15. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087 [TBL] [Abstract][Full Text] [Related]
16. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model. El-Azizi M; Farag N; Khardori N Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals. Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609 [TBL] [Abstract][Full Text] [Related]
18. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. Seneviratne CJ; Jin LJ; Samaranayake YH; Samaranayake LP Antimicrob Agents Chemother; 2008 Sep; 52(9):3259-66. PubMed ID: 18625775 [TBL] [Abstract][Full Text] [Related]
19. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687 [TBL] [Abstract][Full Text] [Related]
20. Time course analysis of Candida albicans metabolites during biofilm development. Zhu Z; Wang H; Shang Q; Jiang Y; Cao Y; Chai Y J Proteome Res; 2013 Jun; 12(6):2375-85. PubMed ID: 22834926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]